Shares of Health Care sector company Amgen moved 0.9% today, and are now trading at a price of $341.46. The Large-Cap stock's daily volume was 310,061 compared to its average volume of 2,369,504. The S&P 500 index returned a 0.0% performance.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company is based in Thousand Oaks and has 28,000 full time employees. Its market capitalization is $183,869,587,456. Amgen currently offers its equity investors a dividend that yields 2.8% per year.
26 analysts are following Amgen and have set target prices ranging from $180.0 to $400.0 per share. On average, they have given the company a rating of buy. At today's prices, AMGN is trading 8.99% away from its average analyst target price of $313.3 per share.
Over the last year, AMGN's share price has increased by 12.3%, which represents a difference of -2.1% when compared to the S&P 500. The stock's 52 week high is $341.5 per share whereas its 52 week low is $253.3. With average free cash flows of $8.89 Billion that have been growing at an average rate of 2.4% over the last 5 years, Amgen is in a position to continue its strong stock performance trend.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 11,490,000 | 1,096,000 | 10,394,000 | 41.24 |
| 2023 | 8,471,000 | 1,112,000 | 7,359,000 | -16.23 |
| 2022 | 9,721,000 | 936,000 | 8,785,000 | 4.82 |
| 2021 | 9,261,000 | 880,000 | 8,381,000 | -15.25 |
| 2020 | 10,497,000 | 608,000 | 9,889,000 | 15.9 |
| 2019 | 9,150,000 | 618,000 | 8,532,000 |
